Preclinical Tomography System for Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (CT, SPECT, Others); Application (Hospital, Research Institute, Other) and Geography

Report Code: TIPRE00022887 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Preclinical imaging is the visualization of living animals for various research purposes, like drug development. The preclinical tomography systems is a molecular imaging system that is designed to provide the solution for molecular imaging research, animal life science etc. Nowadays, multi-modal systems are manufactured combining the advantages of anatomical modalities like CT with the functional imaging of PET and SPECT. They are used to visualize physiological, metabolic and functional information and help in monitoring the progression of various diseases.

MARKET SCOPE

The "Global Preclinical Tomography System for Biopharmaceuticals Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the preclinical tomography system for biopharmaceuticals market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading preclinical tomography system for biopharmaceuticals market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global preclinical tomography system for biopharmaceuticals market is segmented into CT, SPECT, and others.
  •  On the basis of application, the market is bifurcated into hospital, research institute, and other.

MARKET DYNAMICS
Drivers

  •  Rising number of contract research manufacturing and experiments by medical devices companies, robust R&D infrastructure, and increasing drug development activities drive the growth of the market.
  •  Technological advancements in molecular imaging field, growing market demand for non-invasive small-animal imaging techniques, and surging awareness regarding the ill-effects coupled with radiation-based imaging boosts the market growth.
  •  Increasing number of government initiatives and public-private funding to support preclinical researches fuel the growth of preclinical tomography system for biopharmaceuticals market.

Restraints

  •  Strict regulatory framework that governs preclinical researches.
  •  High costs of installation and operations associated with preclinical systems.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The preclinical tomography system for biopharmaceuticals market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the preclinical tomography system for biopharmaceuticals market in these regions.

IMPACT OF COVID-19 ON PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The rising need for antiviral research tools, and to support the testing of coronavirus vaccines and pharmaceuticals, led to growing demand of the system. As the non-invasive lung imaging can provide researchers the ability to precisely determine the location of pathological processes for high-throughput screening of respiratory syndrome-associated coronavirus genotype and these capabilities will assist researchers in screening for therapy candidates. Hence, the market is expected to witness substantial growth, as the cases are rising and there is emerging demand for research and drug discovery.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the preclinical tomography system for biopharmaceuticals market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from preclinical tomography system for biopharmaceuticals market are anticipated to have lucrative growth opportunities in the future with the rising demand for preclinical tomography system for biopharmaceuticals in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the preclinical tomography system for biopharmaceuticals market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Bruker
  •  MILabs
  •  MR Solutions
  •  Mediso
  •  Trifoil Imaging
  •  PerkinElmer
  •  Sedecal
  •  Scanco Medical
  •  Delta Electronics
  •  GE Healthcare

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Preclinical Tomography System For Biopharmaceuticals Market - By Type
1.3.2 Preclinical Tomography System For Biopharmaceuticals Market - By Application
1.3.3 Preclinical Tomography System For Biopharmaceuticals Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET - GLOBAL MARKET ANALYSIS
6.1. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS - GLOBAL MARKET OVERVIEW
6.2. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING

7. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. CT
7.3.1. Overview
7.3.2. CT Market Forecast and Analysis
7.4. SPECT
7.4.1. Overview
7.4.2. SPECT Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. RESEARCH INSTITUTE
8.4.1. Overview
8.4.2. Research Institute Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis

9. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Preclinical Tomography System For Biopharmaceuticals Market Overview
9.1.2 North America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis
9.1.3 North America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Type
9.1.4 North America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Application
9.1.5 North America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Preclinical Tomography System For Biopharmaceuticals Market
9.1.5.1.1 Canada Preclinical Tomography System For Biopharmaceuticals Market by Type
9.1.5.1.2 Canada Preclinical Tomography System For Biopharmaceuticals Market by Application
9.1.5.2 Mexico Preclinical Tomography System For Biopharmaceuticals Market
9.1.5.2.1 Mexico Preclinical Tomography System For Biopharmaceuticals Market by Type
9.1.5.2.2 Mexico Preclinical Tomography System For Biopharmaceuticals Market by Application
9.1.5.3 US Preclinical Tomography System For Biopharmaceuticals Market
9.1.5.3.1 US Preclinical Tomography System For Biopharmaceuticals Market by Type
9.1.5.3.2 US Preclinical Tomography System For Biopharmaceuticals Market by Application
9.2. EUROPE
9.2.1 Europe Preclinical Tomography System For Biopharmaceuticals Market Overview
9.2.2 Europe Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis
9.2.3 Europe Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Type
9.2.4 Europe Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Application
9.2.5 Europe Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Preclinical Tomography System For Biopharmaceuticals Market
9.2.5.1.1 Germany Preclinical Tomography System For Biopharmaceuticals Market by Type
9.2.5.1.2 Germany Preclinical Tomography System For Biopharmaceuticals Market by Application
9.2.5.2 France Preclinical Tomography System For Biopharmaceuticals Market
9.2.5.2.1 France Preclinical Tomography System For Biopharmaceuticals Market by Type
9.2.5.2.2 France Preclinical Tomography System For Biopharmaceuticals Market by Application
9.2.5.3 Italy Preclinical Tomography System For Biopharmaceuticals Market
9.2.5.3.1 Italy Preclinical Tomography System For Biopharmaceuticals Market by Type
9.2.5.3.2 Italy Preclinical Tomography System For Biopharmaceuticals Market by Application
9.2.5.4 Spain Preclinical Tomography System For Biopharmaceuticals Market
9.2.5.4.1 Spain Preclinical Tomography System For Biopharmaceuticals Market by Type
9.2.5.4.2 Spain Preclinical Tomography System For Biopharmaceuticals Market by Application
9.2.5.5 United Kingdom Preclinical Tomography System For Biopharmaceuticals Market
9.2.5.5.1 United Kingdom Preclinical Tomography System For Biopharmaceuticals Market by Type
9.2.5.5.2 United Kingdom Preclinical Tomography System For Biopharmaceuticals Market by Application
9.2.5.6 Rest of Europe Preclinical Tomography System For Biopharmaceuticals Market
9.2.5.6.1 Rest of Europe Preclinical Tomography System For Biopharmaceuticals Market by Type
9.2.5.6.2 Rest of Europe Preclinical Tomography System For Biopharmaceuticals Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market Overview
9.3.2 Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis
9.3.3 Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Preclinical Tomography System For Biopharmaceuticals Market
9.3.5.1.1 Australia Preclinical Tomography System For Biopharmaceuticals Market by Type
9.3.5.1.2 Australia Preclinical Tomography System For Biopharmaceuticals Market by Application
9.3.5.2 China Preclinical Tomography System For Biopharmaceuticals Market
9.3.5.2.1 China Preclinical Tomography System For Biopharmaceuticals Market by Type
9.3.5.2.2 China Preclinical Tomography System For Biopharmaceuticals Market by Application
9.3.5.3 India Preclinical Tomography System For Biopharmaceuticals Market
9.3.5.3.1 India Preclinical Tomography System For Biopharmaceuticals Market by Type
9.3.5.3.2 India Preclinical Tomography System For Biopharmaceuticals Market by Application
9.3.5.4 Japan Preclinical Tomography System For Biopharmaceuticals Market
9.3.5.4.1 Japan Preclinical Tomography System For Biopharmaceuticals Market by Type
9.3.5.4.2 Japan Preclinical Tomography System For Biopharmaceuticals Market by Application
9.3.5.5 South Korea Preclinical Tomography System For Biopharmaceuticals Market
9.3.5.5.1 South Korea Preclinical Tomography System For Biopharmaceuticals Market by Type
9.3.5.5.2 South Korea Preclinical Tomography System For Biopharmaceuticals Market by Application
9.3.5.6 Rest of Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market
9.3.5.6.1 Rest of Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market by Type
9.3.5.6.2 Rest of Asia-Pacific Preclinical Tomography System For Biopharmaceuticals Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market Overview
9.4.2 Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis
9.4.3 Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Preclinical Tomography System For Biopharmaceuticals Market
9.4.5.1.1 South Africa Preclinical Tomography System For Biopharmaceuticals Market by Type
9.4.5.1.2 South Africa Preclinical Tomography System For Biopharmaceuticals Market by Application
9.4.5.2 Saudi Arabia Preclinical Tomography System For Biopharmaceuticals Market
9.4.5.2.1 Saudi Arabia Preclinical Tomography System For Biopharmaceuticals Market by Type
9.4.5.2.2 Saudi Arabia Preclinical Tomography System For Biopharmaceuticals Market by Application
9.4.5.3 U.A.E Preclinical Tomography System For Biopharmaceuticals Market
9.4.5.3.1 U.A.E Preclinical Tomography System For Biopharmaceuticals Market by Type
9.4.5.3.2 U.A.E Preclinical Tomography System For Biopharmaceuticals Market by Application
9.4.5.4 Rest of Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market
9.4.5.4.1 Rest of Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market by Type
9.4.5.4.2 Rest of Middle East and Africa Preclinical Tomography System For Biopharmaceuticals Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Preclinical Tomography System For Biopharmaceuticals Market Overview
9.5.2 South and Central America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis
9.5.3 South and Central America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Type
9.5.4 South and Central America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Application
9.5.5 South and Central America Preclinical Tomography System For Biopharmaceuticals Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Preclinical Tomography System For Biopharmaceuticals Market
9.5.5.1.1 Brazil Preclinical Tomography System For Biopharmaceuticals Market by Type
9.5.5.1.2 Brazil Preclinical Tomography System For Biopharmaceuticals Market by Application
9.5.5.2 Argentina Preclinical Tomography System For Biopharmaceuticals Market
9.5.5.2.1 Argentina Preclinical Tomography System For Biopharmaceuticals Market by Type
9.5.5.2.2 Argentina Preclinical Tomography System For Biopharmaceuticals Market by Application
9.5.5.3 Rest of South and Central America Preclinical Tomography System For Biopharmaceuticals Market
9.5.5.3.1 Rest of South and Central America Preclinical Tomography System For Biopharmaceuticals Market by Type
9.5.5.3.2 Rest of South and Central America Preclinical Tomography System For Biopharmaceuticals Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PRECLINICAL TOMOGRAPHY SYSTEM FOR BIOPHARMACEUTICALS MARKET, KEY COMPANY PROFILES
11.1. BRUKER
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MILABS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MR SOLUTIONS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MEDISO
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TRIFOIL IMAGING
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PERKINELMER
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SEDECAL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SCANCO MEDICAL
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. DELTA ELECTRONICS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GE HEALTHCARE
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Bruker
2. MILabs
3. MR Solutions
4. Mediso
5. Trifoil Imaging
6. PerkinElmer
7. Sedecal
8. Scanco Medical
9. Delta Electronics
10. GE Healthcare
TIPRE00022887
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking